0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Tissue Engineering Market by Type (Synthetic Scaffold Material, Biologically Derived Scaffold Material, and Others), Application (Orthopedics & Musculoskeletal, Neurology, Cardiovascular, Skin & Integumentary, Dental, and Others): Global Opportunity Analysis and Industry Forecast, 2020–2027
Published Date: October 2020
|
Report Code: ALLI-Auto-1B403
Home | Market Reports | Science| Biological Sciences
Tissue Engineering Market by Type Synthetic Scaffold Material Biologically Derived Scaffold Material and Others Application Orthopedics Musculoskeletal Neurology Cardiovascular Skin Integumentary Dental and Others Global Opportunity Analysis and Industry Forecast 2020 2027
BUY CHAPTERS

Tissue Engineering Market by Type (Synthetic Scaffold Material, Biologically Derived Scaffold Material, and Others), Application (Orthopedics & Musculoskeletal, Neurology, Cardiovascular, Skin & Integumentary, Dental, and Others): Global Opportunity Analysis and Industry Forecast, 2020–2027

Code: ALLI-Auto-1B403
Report
October 2020
Pages:227
Allied Market Research
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Tissue Engineering Market 

The global tissue engineering market size was valued at USD 2374 Million in 2019 and is forecasted to reach a size of USD 6815 Million by 2027 at a CAGR of 14.2% from 2020 to 2027. Key drivers of the tissue engineering market include the rising incidences of chronic diseases and trauma emergencies along with awareness regarding tissue engineering therapies. 

Tissue Engineering Market

The technological advancements in 3D bioprinting and R&D activities will fuel the growth of the tissue engineering market in the coming years. Commercialization of tissue-engineered products and spurt in regenerative medicine use will provide huge scope for market expansion. However, high costs, strict government rules, and covid 19 restrictions will hamper the tissue engineering market growth in the subsequent years.

Trends Influencing the Global Tissue Engineering Market 

Growing diseases such as diabetes, obesity, trauma cases, and rising awareness levels

Skin loss happens due to a variety of reasons such as diabetes, thermal injuries, chronic ulcer, pressure, venous stasis, etc. Chronic wounds and injuries degrade the quality of life and lead to disability, imbalance, amputation, or even death. People are opting for therapeutic interventions through tissue-engineered skin replacements for restoring functional, structural properties to the affected skin mass. The increasing recognizance of reengineered tissues and organs has helped end the pain of debilitating diseases and wounds. This in turn will drive the growth of the tissue engineering market in the upcoming years. 

The emergence of newer technologies

3D printing, skin grafting, bioartificial organs, biomimetics, and materials are the latest technological solutions for accelerating the body’s healing capacity and stimulating regeneration. Several 3D printed constructs and scaffolding equipment have been approved to provide cellular differentiation and reconstruction of wounded body tissues. The rapid innovations and launching of a variety of advanced equipment by key players will continue further accelerating the growth of the tissue engineering market during the review period.

The rise in preference for regenerative medicine and largescale commercialization

Stem cell research and regenerative therapies are gaining traction worldwide. These biomedical and cell research methodologies have the potential to revolutionize the medical industry. They are being applied to regenerate certain body tissues and organs or growing artificial parts in laboratories for completely replacing the original organ. Bones, cartilage, blood vessels, cardiovascular repair, and bladder can be imitated artificially to restore normal functioning. Preventive care also forms an essential part of the regenerative process. Moreover, the rapid commercialization is aiding in the overall growth of the market. These factors will significantly boost the tissue engineering market growth in the future. 

Costly and covid 19 impact

There are a host of potential benefits to this industry. But the high research and development costs, lower profit margins, and escalating manufacturing prices will severely restrict the market.  It remains out of reach of the majority of the population. Moreover with the ongoing covid 19 pandemic pharmaceutical and biotech companies have shifted their focus to developing covid vaccines and research on possible treatments. All non-essential clinical trials and resource spending has been halted. The stringent government rules further complicate the process. This in turn will restrain the growth of the tissue engineering market in the subsequent years.

Tissue Engineering Market Share Analysis 

Based on type, the biologically derived scaffolding material dominated the market in 2019 and will continue to provide lucrative opportunities for growth in the tissue engineering market share due to its biodegradability, non-toxic, quick cellular matching, and easy functioning process. On the other hand, synthetic materials will grow the fastest due to their effectiveness.

Based on application, the orthopedics and musculoskeletal segment will maintain dominance in the tissue engineering market share due to growing musculoskeletal disorders and the presence of various options such as the spine, bone substitute, graft, cartilage, etc. However, the cardiovascular segment will grow rapidly due to leading innovations and research activities.

Based on region, North America will provide huge growth opportunities in the tissue engineering market share due to developed infrastructure and rising chronic diseases. The Asia-Pacific segment will grow at the highest CAGR of 16.3% due to technological advancements and disorders.

Tissue Engineering Market Segmentation

By Type

    • Synthetic Scaffold Material
      • Synthetic Polymer
      • Others
    • Biologically Derived Scaffold Material
      • Collagen
      • Others
    • Others

By Application

    • Orthopedics and Musculoskeletal
    • Neurology
    • Cardiovascular
    • Skin and Integumentary
    • Dental
    • Others

By Region

    • North America
      • U.S.
      • Canada
      • Mexico
    • Europe
      • Germany
      • France
      • UK
      • Italy
      • Spain
      • Rest of Europe
    • Asia-Pacific
      • Japan
      • China
      • Australia
      • India
      • South Korea
      • Rest of Asia-Pacific
    • LAMEA
      • Latin America
      • Middle East and Africa

By Companies

  • Abbvie Inc. (Allergen Plc.)
  • Braun Melsungen Ag
  • Becton, Dickinson And Company (C. R. Bard, Inc.)
  • Integra Lifesciences
  • Organogenesis Holdings
  • Sid Martin Biotech (Axogen)
  • Smith & Nephew Plc. (Osiris Therapeutics)
  • Tissuetech Inc.
  • Vericel Corporation
  • Zimmer Biomet Holdings, Inc.

Scope of Tissue Engineering Market Report

Report Metric

Details

Report Name

Tissue Engineering Market

Market size value in 2019

USD 2,374 Million

Revenue forecast in 2027

USD 6,815 Million

Growth Rate

14.2%

Base year considered

2019

Forecast Period

2020-2027

By Type

Synthetic Scaffold Material, Biologically Derived Scaffold Material

By Application

Orthopedics & Musculoskeletal, Neurology, Cardiovascular, Skin & Integumentary, Dental

Report Coverage

Revenue & volume forecast, company share, competitive landscape, growth factors, and trends

Segments Covered

By Type, Application, and Region

Geographic Regions Covered

North America, Europe, Asia Pacific, Latin America, Middle East & Africa

Frequently Asked Questions About This Report 

1. How big is the Tissue Engineering Market?

Ans. The global tissue engineering market was valued at $2,374 million in 2019, and is projected to reach $6,815 million by 2027, registering a CAGR of 14.2% from 2020 to 2027.

2. Who are the key players available in the Tissue Engineering Industry?

Ans. The key players profiled in this report include  AbbVie Inc. (Allergen Plc.), B. Braun Melsungen AG, Becton, Dickinson and Company (C. R. BARD, INC.), Integra LifeSciences, Organogenesis Holdings, Sid Martin Biotech (Axogen), Smith & Nephew Plc. (Osiris Therapeutics), TissueTech Inc.

3. Does the report provides covid-19 impact analysis?

Ans. Yes, the report includes a COVID-19 impact analysis. Also, it is further extended into every individual segment of the report.

Chapter 1:Introduction
1.1.Report description
1.2.Key benefits for stakeholders
1.3.Key market segments
1.3.1.List of key players profiled in the report
1.4.Research methodology
1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models
Chapter 2:Executive Summary
2.1.Key findings of the study
2.2.CXO perspective
Chapter 3:Market landscape
3.1.Market definition and scope
3.2.Key findings
3.2.1.Top investment pockets
3.2.2.Top winning strategies
3.3.Porter’s five force analysis
3.4.Top player positioning, 2019
3.5.Market dynamics
3.5.1.Drivers
3.5.1.1.Increase in need for tissue engineering in organ transplantation
3.5.1.2.Advancements in medical equipment technologies
3.5.1.3.Increase in prevalence of chronic diseases and trauma emergencies
3.5.2.Restraint
3.5.2.1.High cost associated with tissue engineered products
3.5.2.2.Hurdles associated with tissue engineering
3.5.3.Opportunity
3.5.3.1.Growth opportunities in emerging markets
3.5.4.Impact analysis
3.6.Market information on kidney and liver tissue engineering
3.7.Market overview: product segment
3.7.1.Cell Therapy
3.7.2.Gene Therapy
3.7.3.Small molecules and biologics
3.8.COVID-19 impact analysis on tissue engineering market
Chapter 4:Tissue Engineering MARKET, BY type
4.1.Overview
4.1.1.Market size and forecast
4.2.Synthetic scaffold material
4.2.1.Key market trends growth factors and opportunities
4.2.2.Market size and forecast, by type
4.2.2.1.Synthetic polymer
4.2.2.2.Others
4.2.3.Market size and forecast, by region
4.2.4.Market analysis, by country
4.3.Biologically derived scaffold materials
4.3.1.Key market trends growth factors and opportunities
4.3.2.Market size and forecast, by type
4.3.2.1.Collagen
4.3.2.2.Others
4.3.3.Market size and forecast, by region
4.3.4.Market analysis, by country
4.4.Others
4.4.1.Key market trends, growth factors, and opportunities
4.4.2.Market size and forecast, by region
4.4.3.Market analysis, by country
Chapter 5:Tissue Engineering MARKET, BY Application
5.1.Overview
5.1.1.Market size and forecast
5.2.Orthopedics & musculoskeletal
5.2.1.Market size and forecast, by region
5.2.2.Market analysis, by country
5.3.Neurology
5.3.1.Market size and forecast, by region
5.3.2.Market analysis, by country
5.4.Cardiovascular
5.4.1.Market size and forecast, by region
5.4.2.Market analysis, by country
5.5.Skin & integumentary
5.5.1.Market size and forecast, by region
5.5.2.Market analysis, by country
5.6.Dental
5.6.1.Market size and forecast, by region
5.6.2.Market analysis, by country
5.7.Others
5.7.1.Market size and forecast, by region
5.7.2.Market analysis, by country
Chapter 6:Tissue Engineering MARKET, BY Region
6.1.Overview
6.1.1.Market size and forecast
6.2.North America
6.2.1.Key market trends, key growth factors and opportunities
6.2.2.Market size and forecast, by country
6.2.2.1.U.S.
6.2.2.1.1.U.S. tissue engineering market, by type
6.2.2.1.2.U.S. tissue engineering market, by application
6.2.2.2.Canada
6.2.2.2.1.Canada tissue engineering market, by type
6.2.2.2.2.Canada tissue engineering market, by application
6.2.2.3.Mexico
6.2.2.3.1.Mexico tissue engineering market, by type
6.2.2.3.2.Mexico tissue engineering market, by application
6.2.3.North America market size and forecast, by type
6.2.4.North America market size and forecast, by application
6.3.Europe
6.3.1.Key market trends, growth factors, and opportunities
6.3.2.Market size and forecast, by country
6.3.2.1.Germany
6.3.2.1.1.Germany tissue engineering market, by type
6.3.2.1.2.Germany tissue engineering market, by application
6.3.2.2.France
6.3.2.2.1.France tissue engineering market, by type
6.3.2.2.2.France tissue engineering market, by application
6.3.2.3.UK
6.3.2.3.1.UK tissue engineering market, by type
6.3.2.3.2.UK tissue engineering market, by application
6.3.2.4.Italy
6.3.2.4.1.Italy tissue engineering market, by type
6.3.2.4.2.Italy tissue engineering market, by application
6.3.2.5.Spain
6.3.2.5.1.Spain tissue engineering market, by type
6.3.2.5.2.Spain tissue engineering market, by application
6.3.2.6.Rest of Europe
6.3.2.6.1.Rest of Europe tissue engineering market, by type
6.3.2.6.2.Rest of Europe tissue engineering market, by application
6.3.3.Europe market size and forecast, by type
6.3.4.Europe market size and forecast, by application
6.4.Asia-pacific
6.4.1.Key market trends, growth factors, and opportunities
6.4.2.Market size and forecast
6.4.2.1.Japan
6.4.2.1.1.Japan tissue engineering market, by type
6.4.2.1.2.Japan tissue engineering market, by application
6.4.2.2.China
6.4.2.2.1.China tissue engineering market, by type
6.4.2.2.2.China tissue engineering market, by application
6.4.2.3.Australia
6.4.2.3.1.Australia tissue engineering market, by type
6.4.2.3.2.Australia tissue engineering market, by application
6.4.2.4.India
6.4.2.4.1.India tissue engineering market, by type
6.4.2.4.2.India tissue engineering market, by application
6.4.2.5.South Korea
6.4.2.5.1.South Korea tissue engineering market, by type
6.4.2.5.2.South Korea tissue engineering market, by application
6.4.2.6.Rest of Asia-Pacific market size and forecast
6.4.2.6.1.Rest of Asia-Pacific tissue engineering market, by type
6.4.2.6.2.Rest of Asia-Pacific tissue engineering market, by application
6.4.3.Asia-pacific market size and forecast, by type
6.4.4.Asia-pacific market size and forecast, by application
6.5.LAMEA
6.5.1.Key market trends, growth factors, and opportunities
6.5.2.Market size and forecast
6.5.2.1.Latin America
6.5.2.1.1.Latin America tissue engineering market, by type
6.5.2.1.2.Latin America tissue engineering market, by application
6.5.2.2.Middle East & Africa
6.5.2.2.1.Middle East & Africa tissue engineering market, by type
6.5.2.2.2.Middle East & Africa tissue engineering market, by application
6.5.3.LAMEA market size and forecast, by type
6.5.4.LAMEA market size and forecast, by application
Chapter 7:Company profiles
7.1.ABBVIE INC. (ALLERGEN PLC.)
7.1.1.Company overview
7.1.2.Company snapshot
7.1.3.Operating business segments
7.1.4.Product portfolio
7.1.5.Business performance
7.1.6.Key strategic moves and developments
7.2.B. BRAUN MELSUNGEN AG
7.2.1.Company overview
7.2.2.Company snapshot
7.2.3.Operating business segments
7.2.4.Product portfolio
7.2.5.Business performance
7.3.BECTON, DICKINSON AND COMPANY (C. R. BARD, INC.)
7.3.1.Company overview
7.3.2.Company snapshot
7.3.3.Operating business segments
7.3.4.Product portfolio
7.3.5.Business performance
7.3.6.Key strategic moves and developments
7.4.INTEGRA LIFESCIENCES
7.4.1.Company overview
7.4.2.Company snapshot
7.4.3.Operating business segments
7.4.4.Product portfolio
7.4.5.Business performance
7.4.6.Key strategic moves and developments
7.5.ORGANOGENESIS HOLDINGS
7.5.1.Company overview
7.5.2.Company snapshot
7.5.3.Operating business segments
7.5.4.Product portfolio
7.5.5.Business performance
7.5.6.Key strategic moves and developments
7.6.SID MARTIN BIOTECH (AXOGEN)
7.6.1.Company overview
7.6.2.Company snapshot
7.6.3.Operating business segments
7.6.4.Product portfolio
7.6.5.Business performance
7.6.6.Key strategic moves and developments
7.7.SMITH & NEPHEW PLC. (OSIRIS THERAPEUTICS)
7.7.1.Company overview
7.7.2.Company snapshot
7.7.3.Operating business segments
7.7.4.Product portfolio
7.7.5.Business performance
7.7.6.Key strategic moves and developments
7.8.TISSUETECH INC.
7.8.1.Company overview
7.8.2.Company snapshot
7.8.3.Operating business segments
7.8.4.Product portfolio
7.9.VERICEL CORPORATION
7.9.1.Company overview
7.9.2.Company snapshot
7.9.3.Operating business segments
7.9.4.Product portfolio
7.9.5.Business performance.
7.9.6.Key strategic moves and developments
7.10.ZIMMER BIOMET HOLDINGS, INC.
7.10.1.Company overview
7.10.2.Company snapshot
7.10.3.Operating business segments
7.10.4.Product portfolio
7.10.5.BUSINESS PERFORMANC
LIST OF TABLES

TABLE 01.GLOBAL TISSUE ENGINEERING MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 02.GLOBAL SYNTHETIC SCAFFOLD MATERIAL MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 03.SYNTHETIC SCAFFOLD MATERIAL TISSUE ENGINEERING MARKET, BY REGION, 2019–2027 ($MILLION)
TABLE 04.GLOBAL BIOLOGICALLY DERIVED SCAFFOLD MATERIAL MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 05.BIOLOGICALLY DERIVED SCAFFOLD MATERIALS TISSUE ENGINEERING MARKET, BY REGION, 2019–2027 ($MILLION)
TABLE 06.OTHERS TISSUE ENGINEERING MARKET, BY REGION, 2019–2027 ($MILLION)
TABLE 07.GLOBAL TISSUE ENGINEERING MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 08.ORTHOPEDICS & MUSCULOSKELETAL TISSUE ENGINEERING MARKET, BY REGION, 2019–2027 ($MILLION)
TABLE 09.NEUROLOGY TISSUE ENGINEERING MARKET, BY REGION, 2019–2027 ($MILLION)
TABLE 10.CARDIOVASCULAR TISSUE ENGINEERING MARKET, BY REGION, 2019–2027 ($MILLION)
TABLE 11.SKIN & INTEGUMENTARY TISSUE ENGINEERING MARKET, BY REGION, 2019–2027 ($MILLION)
TABLE 12.DENTAL TISSUE ENGINEERING MARKET, BY REGION, 2019–2027 ($MILLION)
TABLE 13.OTHERS TISSUE ENGINEERING MARKET, BY REGION, 2019–2027 ($MILLION)
TABLE 14.GLOBAL TISSUE ENGINEERING MARKET, BY REGION, 2019–2027 ($MILLION)
TABLE 15.NORTH AMERICA TISSUE ENGINEERING MARKET, BY COUNTRY, 2019–2027 ($MILLION)
TABLE 16.U.S. TISSUE ENGINEERING MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 17.U.S. TISSUE ENGINEERING MARKET, BY APPLICATION , 2019–2027 ($MILLION)
TABLE 18.CANADA TISSUE ENGINEERING MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 19.CANADA TISSUE ENGINEERING MARKET, BY APPLICATION , 2019–2027 ($MILLION)
TABLE 20.MEXICO TISSUE ENGINEERING MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 21.MEXICO TISSUE ENGINEERING MARKET, BY APPLICATION , 2019–2027 ($MILLION)
TABLE 22.NORTH AMERICA TISSUE ENGINEERING MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 23.NORTH AMERICA TISSUE ENGINEERING MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 24.EUROPE TISSUE ENGINEERING MARKET, BY COUNTRY, 2019–2027 ($MILLION)
TABLE 25.GERMANY TISSUE ENGINEERING MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 26.GERMANY TISSUE ENGINEERING MARKET, BY APPLICATION , 2019–2027 ($MILLION)
TABLE 27.FRANCE TISSUE ENGINEERING MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 28.FRANCE TISSUE ENGINEERING MARKET, BY APPLICATION , 2019–2027 ($MILLION)
TABLE 29.UK TISSUE ENGINEERING MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 30.UK TISSUE ENGINEERING MARKET, BY APPLICATION , 2019–2027 ($MILLION)
TABLE 31.ITALY TISSUE ENGINEERING MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 32.ITALY TISSUE ENGINEERING MARKET, BY APPLICATION , 2019–2027 ($MILLION)
TABLE 33.SPAIN TISSUE ENGINEERING MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 34.SPAIN TISSUE ENGINEERING MARKET, BY APPLICATION , 2019–2027 ($MILLION)
TABLE 35.REST OF EUROPE TISSUE ENGINEERING MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 36.REST OF EUROPE TISSUE ENGINEERING MARKET, BY APPLICATION , 2019–2027 ($MILLION)
TABLE 37.EUROPE TISSUE ENGINEERING MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 38.EUROPE TISSUE ENGINEERING MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 39.ASIA-PACIFIC TISSUE ENGINEERING MARKET, BY COUNTRY, 2019–2027 ($MILLION)
TABLE 40.JAPAN TISSUE ENGINEERING MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 41.JAPAN TISSUE ENGINEERING MARKET, BY APPLICATION , 2019–2027 ($MILLION)
TABLE 42.CHINA TISSUE ENGINEERING MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 43.CHINA TISSUE ENGINEERING MARKET, BY APPLICATION , 2019–2027 ($MILLION)
TABLE 44.AUSTRALIA TISSUE ENGINEERING MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 45.AUSTRALIA TISSUE ENGINEERING MARKET, BY APPLICATION , 2019–2027 ($MILLION)
TABLE 46.INDIA TISSUE ENGINEERING MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 47.INDIA TISSUE ENGINEERING MARKET, BY APPLICATION , 2019–2027 ($MILLION)
TABLE 48.SOUTH KOREA TISSUE ENGINEERING MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 49.SOUTH KOREA TISSUE ENGINEERING MARKET, BY APPLICATION , 2019–2027 ($MILLION)
TABLE 50.REST OF ASIA-PACIFIC TISSUE ENGINEERING MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 51.REST OF ASIA-PACIFIC TISSUE ENGINEERING MARKET, BY APPLICATION , 2019–2027 ($MILLION)
TABLE 52.ASIA-PACIFIC TISSUE ENGINEERING MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 53.ASIA-PACIFIC TISSUE ENGINEERING MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 54.LAMEA TISSUE ENGINEERING MARKET, BY COUNTRY, 2019–2027 ($MILLION)
TABLE 55.LATIN AMERICA TISSUE ENGINEERING MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 56.LATIN AMERICA TISSUE ENGINEERING MARKET, BY APPLICATION , 2019–2027 ($MILLION)
TABLE 57.MIDDLE EAST & AFRICA TISSUE ENGINEERING MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 58.MIDDLE EAST & AFRICA TISSUE ENGINEERING MARKET, BY APPLICATION , 2019–2027 ($MILLION)
TABLE 59.LAMEA TISSUE ENGINEERING MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 60.LAMEA TISSUE ENGINEERING MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 61.ABBVIE: COMPANY SNAPSHOT
TABLE 62.ABBVIE: OERATING SEGMENT
TABLE 63.ABBVIE: PRODUCT PORTFOLIO
TABLE 64.ABBVIE: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 65.B BRAUN: COMPANY SNAPSHOT
TABLE 66.B BRAUN: PRODUCT SEGMENTS
TABLE 67.B BRAUN: PRODUCT PORTFOLIO
TABLE 68.BD: COMPANY SNAPSHOT
TABLE 69.BD: OERATING SEGMENT
TABLE 70.BD: PRODUCT PORTFOLIO
TABLE 71.BD: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 72.INTEGRA: COMPANY SNAPSHOT
TABLE 73.INTEGRA: OPERATING BUSINESS SEGMENTS
TABLE 74.INTEGRA: PRODUCT PORTFOLIO
TABLE 75.ORGANOGENESIS: COMPANY SNAPSHOT
TABLE 76.ORGANOGENESIS: OPERATING SEGMENTS
TABLE 77.ORGANOGENESIS: PRODUCT PORTFOLIO
TABLE 78.AXOGEN: COMPANY SNAPSHOT
TABLE 79.AXOGEN: OPERATING SEGMENTS
TABLE 80.AXOGEN: PRODUCT PORTFOLIO
TABLE 81.AXOGEN: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 82.SMITH & NEPHEW: COMPANY SNAPSHOT
TABLE 83.SMITH & NEPHEW: OPERATING SEGMENTS
TABLE 84.SMITH & NEPHEW: PRODUCT PORTFOLIO
TABLE 85.TISSUETECH: COMPANY SNAPSHOT
TABLE 86.TISSUETECH: OPERATING BUSINESS SEGMENTS
TABLE 87.HOLOGIC: PRODUCT PORTFOLIO
TABLE 88.VERICEL: COMPANY SNAPSHOT
TABLE 89.VERICEL: OPERATING SEGMENTS
TABLE 90.VERICEL: PRODUCT PORTFOLIO
TABLE 91.ZIMMER BIOMET: COMPANY SNAPSHOT
TABLE 92.ZIMMER BIOMET: OPERATING SEGMENTS
TABLE 93.ZIMMER BIOMET: PRODUCT PORTFOLIO LIST OF FIGURES

FIGURE 01.TISSUE ENGINEERING MARKET SEGMENTATION
FIGURE 02.TOP INVESTMENT POCKETS
FIGURE 03.TOP WINNING STRATEGIES, BY YEAR, 2017–2020
FIGURE 04.TOP WINNING STRATEGIES, BY DEVELOPMENT, 2017–2020
FIGURE 05.TOP WINNING STRATEGIES, BY COMPANY, 2017–2020
FIGURE 06.MODERATE BARGAINING POWER OF SUPPLIERS
FIGURE 07.MODERATE BARGAINING POWER OF BUYERS
FIGURE 08.LOW THREAT OF SUBSTITUTES
FIGURE 09.MODERATE THREAT OF NEW ENTRANTS
FIGURE 10.HIGH INTENSITY OF RIVALRY
FIGURE 11.TOP PLAYER POSITIONING, 2019
FIGURE 12.IMPACT ANALYSIS:
FIGURE 13.SYNTHETIC POLYMER MARKET, 2019 - 2027 ($MILLION)
FIGURE 14.OTHERS MARKET, 2019 - 2027 ($MILLION)
FIGURE 15.COMPARATIVE ANALYSIS SYNTHETIC SCAFFOLD MATERIAL TISSUE ENGINEERING MARKET, BY COUNTRY, 2019 & 2027 ($MILLION)
FIGURE 16.COLLAGEN MARKET, BY COUNTRY, 2019 & 2027 ($MILLION)
FIGURE 17.OTHERS MARKET, BY COUNTRY, 2019 & 2027 ($MILLION)
FIGURE 18.COMPARATIVE ANALYSIS BIOLOGICALLY DERIVED SCAFFOLD MATERIALS TISSUE ENGINEERING MARKET, BY COUNTRY, 2019 & 2027 ($MILLION)
FIGURE 19.COMPARATIVE ANALYSIS OTHERS TISSUE ENGINEERING MARKET, BY COUNTRY, 2019 & 2027 ($MILLION)
FIGURE 20.COMPARATIVE ANALYSIS ORTHOPEDICS & MUSCULOSKELETAL TISSUE ENGINEERING MARKET, BY COUNTRY, 2019 & 2027 ($MILLION)
FIGURE 21.COMPARATIVE ANALYSIS NEUROLOGY TISSUE ENGINEERING MARKET, BY COUNTRY, 2019 & 2027 ($MILLION)
FIGURE 22.COMPARATIVE ANALYSIS CARDIOVASCULAR TISSUE ENGINEERING MARKET, BY COUNTRY, 2019 & 2027 ($MILLION)
FIGURE 23.COMPARATIVE ANALYSIS SKIN & INTEGUMENTARY TISSUE ENGINEERING MARKET, BY COUNTRY, 2019 & 2027 ($MILLION)
FIGURE 24.COMPARATIVE ANALYSIS DENTAL TISSUE ENGINEERING MARKET, BY COUNTRY, 2019 & 2027 ($MILLION)
FIGURE 25.COMPARATIVE ANALYSIS OTHERS TISSUE ENGINEERING MARKET, BY COUNTRY, 2019 & 2027 ($MILLION)
FIGURE 26.U.S. TISSUE ENGINEERING MARKET, 2019–2027 ($MILLION)
FIGURE 27.CANADA TISSUE ENGINEERING MARKET, 2019–2027 ($MILLION)
FIGURE 28.MEXICO TISSUE ENGINEERING MARKET, 2019–2027 ($MILLION)
FIGURE 29.GERMANY TISSUE ENGINEERING MARKET, 2019–2027 ($MILLION)
FIGURE 30.FRANCE TISSUE ENGINEERING MARKET, 2019–2027 ($MILLION)
FIGURE 31.UK TISSUE ENGINEERING MARKET, 2019–2027 ($MILLION)
FIGURE 32.ITALY TISSUE ENGINEERING MARKET, 2019–2027 ($MILLION)
FIGURE 33.SPAIN TISSUE ENGINEERING MARKET, 2019–2027 ($MILLION)
FIGURE 34.REST OF EUROPE TISSUE ENGINEERING MARKET, 2019–2027 ($MILLION)
FIGURE 35.JAPAN TISSUE ENGINEERING MARKET, 2019–2027 ($MILLION)
FIGURE 36.CHINA TISSUE ENGINEERING MARKET, 2019–2027 ($MILLION)
FIGURE 37.AUSTRALIA TISSUE ENGINEERING MARKET, 2019–2027 ($MILLION)
FIGURE 38.INDIA TISSUE ENGINEERING MARKET, 2019–2027 ($MILLION)
FIGURE 39.SOUTH KOREA TISSUE ENGINEERING MARKET, 2019–2027 ($MILLION)
FIGURE 40.REST OF ASIA-PACIFIC TISSUE ENGINEERING MARKET, 2019–2027 ($MILLION)
FIGURE 41.LATIN AMERICA TISSUE ENGINEERING MARKET, 2019–2027 ($MILLION)
FIGURE 42.MIDDLE EAST & AFRICA TISSUE ENGINEERING MARKET, 2019–2027 ($MILLION)
FIGURE 43.ABBVIE: NET SALES, 2017–2019 ($MILLION)
FIGURE 44.ABBVIE: REVENUE SHARE, BY REGION, 2019 (%)
FIGURE 45.B BRAUN: NET SALES, 2017–2019 ($MILLION)
FIGURE 46.B BRAUN: REVENUE SHARE, BY SEGMENT, 2019 (%)
FIGURE 47.B BRAUN: REVENUE SHARE, BY REGION, 2019 (%)
FIGURE 48.BD: NET SALES, 2017–2019 ($MILLION)
FIGURE 49.BD: REVENUE SHARE, BY SEGMENT, 2019 (%)
FIGURE 50.BD: REVENUE SHARE, BY REGION, 2019 (%)
FIGURE 51.INTEGRA: NET SALES, 2017–2019 ($MILLION)
FIGURE 52.INTEGRA: REVENUE SHARE, BY SEGMENT, 2019(%)
FIGURE 53.INTEGRA: REVENUE SHARE, BY REGION, 2019(%)
FIGURE 54.ORGANOGENESIS: NET SALES, 2017–2019 ($MILLION)
FIGURE 55.ORGANOGENESIS: REVENUE SHARE, BY SEGMENT, 2019 (%)
FIGURE 56.AXOGEN: NET SALES, 2017–2019 ($MILLION)
FIGURE 57.SMITH & NEPHEW: NET SALES, 2017–2019 ($MILLION)
FIGURE 58.SMITH & NEPHEW: REVENUE SHARE, BY SEGMENT, 2019 (%)
FIGURE 59.SMITH & NEPHEW: REVENUE SHARE, BY REGION, 2019 (%)
FIGURE 60.VERICEL: NET SALES, 2017–2019 ($MILLION)
FIGURE 61.VERICEL: REVENUE SHARE, BY SEGMENT, 2019 (%)
FIGURE 62.ZIMMER BIOMET: NET SALES, 2017–2019 ($MILLION)
FIGURE 63.ZIMMER BIOMET: REVENUE SHARE, BY SEGMENT, 2019 (%)
FIGURE 64.ZIMMER BIOMET: REVENUE SHARE, BY REGION, 2019(%
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$5769

This license allows only one user to access the PDF.
Electronic (PDF)

$6450

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9995

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Electronic (PDF)

$3840

This license just provides quantitative data in a excel sheet
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Accenture

RELATED REPORTS

Global Tissue Microarray Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-22T1016
Sun Feb 11 00:00:00 UTC 2024

Add to Cart

Global miRNA Sequencing and Assay Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-17H7443
Thu Feb 08 00:00:00 UTC 2024

Add to Cart

Global DNA and Gene Chips Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-37V7375
Thu Feb 08 00:00:00 UTC 2024

Add to Cart

Global Automatic Microtome Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-10N7334
Thu Feb 08 00:00:00 UTC 2024

Add to Cart